King Faisal Specialist Hospital & Research Centre (KFSHRC) has become a leader in global healthcare by embracing cutting-edge technologies that push the boundaries of patient care. KFSHRC is making treatments for patients more precise, effective, and easy to get by developing new technologies like CAR T-cell therapy, robotic surgeries, genomic medicine, and advanced digital health solutions.
Traditional cancer treatments like chemotherapy can be a broad approach, often hitting healthy cells as well as cancerous ones. However, KFSHRC is advancing a more targeted solution – CAR T-cell therapy. By harnessing a patient’s immune cells and reprogramming them to attack cancer cells, this therapy offers a personalised treatment for cancers like leukaemia and lymphoma. KFSHRC’s ability to produce these therapeutic cells internally has reduced treatment costs by 80%, making this innovative therapy more accessible to a wider patient base in Saudi Arabia. The reduction from 1.3 million SAR to 250,000 SAR has significantly transformed cancer care in the region.
KFSHRC’s leadership in robotic-assisted surgeries is changing how we think about surgery. For example, the hospital recently performed the world’s first fully robotic Heart transplant for a 16-year-old patient, marking a new era in precision and safety. These minimally invasive procedures allow patients quicker recovery times, less discomfort, and lower complication risks. The youngest patient in the Middle East, a baby boy just two months old, received a heart transplant from KFSHRC. KFSHRC performed this heart transplant using ABO-incompatible technology, a rare procedure that requires world-class expertise.
In another life-saving instance, KFSHRC conducted the first-ever branched stent repair for an abdominal aortic aneurysm in the Middle East. This minimally invasive procedure saved the patient’s life and highlighted the hospital’s capacity to apply advanced surgical techniques in cases where traditional surgery would have been too risky.
In 2023, KFSHRC completed over 5,000 whole-genome sequences, making significant strides in personalized medicine. Genomic testing allows for individualized treatment plans, predicting how patients will respond to specific therapies and enabling doctors to customize treatments accordingly. One of the hospital’s breakthroughs was the discovery of Stenotrophomonas Riyadhensis, a new bacterial strain with important implications for treating infections.
This genomic work also extends to other areas of medicine, such as breast cancer and pulmonary fibrosis. KFSHRC’s digital health infrastructure uses AI-powered tools to figure out the risk of breast cancer and make prognosis models for bone marrow transplants. This gives patients more accurate treatment plans. KFSHRC developed pharmacogenomics services for pulmonary fibrosis to tailor medications to patients based on their genetic profile, further advancing the institution’s commitment to personalised care.
KFSHRC’s advancements in digital health have set a new standard for patient care. With over 185,000 patients seen through virtual clinics in 2023, the hospital has expanded access to care for patients in remote or underserved areas. AI-driven diagnostic tools and digital platforms help streamline care delivery, improving the accuracy and efficiency of treatment. From AI-supported breast cancer detection to predictive models for bone marrow transplants, KFSHRC is incorporating the latest technology to make diagnostics more precise and treatments more effective.
KFSHRC’s leadership extends beyond the Kingdom, as the institution engages in global clinical trials, space medicine research, and partnerships that challenge the limits of modern medicine. By hosting clinical trials and aligning national and international efforts, KFSHRC ensures it remains at the forefront of healthcare advancements. Its contributions to space medicine, including research conducted aboard the International Space Station, demonstrate the hospital’s dedication to expanding medical knowledge that benefits the world.
KFSHRC’s mission is to deliver patient-centred, innovative care that improves outcomes and enhances lives. From pioneering CAR T-cell therapies to performing the world’s first fully robotic liver transplant, KFSHRC is setting new Saudi healthcare standards while influencing the global medical landscape. By combining technology, collaboration, and compassion, KFSHRC is leading the way in making healthcare more personalized, accessible, and effective for patients everywhere.
